Who has invested in VYNE Therapeutics?

Access Biotechnology are named among the investors backing VYNE Therapeutics.

VYNE Therapeutics Funding: $88M Raised, Growth

VYNE Therapeutics funding overview

VYNE Therapeutics has raised $88M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Growth. Investors on record include Access Biotechnology.

VYNE Therapeutics at a glance

Total raised: $88M
Latest round: Growth
Notable investors: Access Biotechnology

Frequently asked about VYNE Therapeutics funding

How much has VYNE Therapeutics raised?: VYNE Therapeutics has raised $88M in total disclosed funding across the rounds on record.
Who has invested in VYNE Therapeutics?: Access Biotechnology are named among the investors backing VYNE Therapeutics.
What was the latest VYNE Therapeutics funding round?: The most recent disclosed round is a Growth.
Where is VYNE Therapeutics based?: No headquarters location is disclosed for VYNE Therapeutics.

Totals shown for VYNE Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies and the investors behind them below.

VYNE Therapeutics Funding: $88M Raised, Growth

VYNE Therapeutics funding overview

VYNE Therapeutics at a glance

Frequently asked about VYNE Therapeutics funding

Companies related to VYNE Therapeutics (17)

Browse related funding lists (3)